JP Morgan Maintains Neutral on Doximity, Raises Price Target to $31

Doximity, Inc. Class A

Doximity, Inc. Class A

DOCS

0.00

JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE: DOCS) with a Neutral and raises the price target from $26 to $31.